Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
If you ask why you keep overspending, you're not alone. This section breaks down frequent triggers and offers concrete fixes to align spending with goals.
22,840 articlesWhen a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Choosing the right healthcare ETF in 2026 hinges on costs, diversification, and your risk tolerance. This analysis pi...
Alphabet plans nearly $185B in capital spending for 2026, mostly on data centers. This article highlights a crucial m...
SpaceX isn’t just about rockets. This investing guide shows how spacex could become most AI company by turning data, ...
Investors often chase the high yield offered by Alphabet's convertible preferred stock. This guide breaks down what t...
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
David Senra has turned down every acquisition proposal for his solo-operated podcast, choosing independence and creat...
Navitas Semiconductor, a noted Nvidia partner, posted a dramatic first-half surge in 2026 as its GaN and SiC power de...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
Missed Sandisk's 580% rally? No worry. You can still ride the AI-driven chip surge with three smart stock picks, clea...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...